KR20240087708A - 구형구축과 관련된 상태의 치료 및 이식체나 그 주위의 섬유성장 억제를 위한 푸칸 및 개질 푸칸 조성물 - Google Patents

구형구축과 관련된 상태의 치료 및 이식체나 그 주위의 섬유성장 억제를 위한 푸칸 및 개질 푸칸 조성물 Download PDF

Info

Publication number
KR20240087708A
KR20240087708A KR1020247009278A KR20247009278A KR20240087708A KR 20240087708 A KR20240087708 A KR 20240087708A KR 1020247009278 A KR1020247009278 A KR 1020247009278A KR 20247009278 A KR20247009278 A KR 20247009278A KR 20240087708 A KR20240087708 A KR 20240087708A
Authority
KR
South Korea
Prior art keywords
medically acceptable
implant
fucan composition
treating
effective amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020247009278A
Other languages
English (en)
Korean (ko)
Inventor
해성 선
이안 밀렛
크리스토퍼 마이클 케빈 스프링게이트
Original Assignee
에이알시 메디컬 디바이시즈 인코포레이션
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 에이알시 메디컬 디바이시즈 인코포레이션 filed Critical 에이알시 메디컬 디바이시즈 인코포레이션
Publication of KR20240087708A publication Critical patent/KR20240087708A/ko
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/23—Carbohydrates
    • A61L2300/232—Monosaccharides, disaccharides, polysaccharides, lipopolysaccharides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Transplantation (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
KR1020247009278A 2021-08-20 2022-08-18 구형구축과 관련된 상태의 치료 및 이식체나 그 주위의 섬유성장 억제를 위한 푸칸 및 개질 푸칸 조성물 Pending KR20240087708A (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163235316P 2021-08-20 2021-08-20
US63/235,316 2021-08-20
US202263354322P 2022-06-22 2022-06-22
US63/354,322 2022-06-22
PCT/CA2022/051254 WO2023019360A1 (en) 2021-08-20 2022-08-18 Fucan and modified fucan compositions for the treatment of conditions related to capsular contracture and to inhibiting fibrous growth around or on transplants

Publications (1)

Publication Number Publication Date
KR20240087708A true KR20240087708A (ko) 2024-06-19

Family

ID=85239322

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020247009278A Pending KR20240087708A (ko) 2021-08-20 2022-08-18 구형구축과 관련된 상태의 치료 및 이식체나 그 주위의 섬유성장 억제를 위한 푸칸 및 개질 푸칸 조성물

Country Status (10)

Country Link
US (1) US20240350531A1 (https=)
EP (1) EP4387630A4 (https=)
JP (1) JP2024532867A (https=)
KR (1) KR20240087708A (https=)
AU (1) AU2022328865A1 (https=)
CA (1) CA3229366A1 (https=)
IL (1) IL310940A (https=)
MX (1) MX2024002190A (https=)
WO (1) WO2023019360A1 (https=)
ZA (1) ZA202401941B (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102024104757B4 (de) * 2024-02-21 2026-03-26 Acandis Gmbh Medizinische Vorrichtung mit verbesserter antithrombotischer Wirkung

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8933290B2 (en) * 2007-06-26 2015-01-13 Sofradim Production Sas Mesh implant
WO2019210414A1 (en) * 2018-05-02 2019-11-07 Arc Medical Devices Inc. Fucan-based compounds and complexes
US11446326B2 (en) * 2018-07-27 2022-09-20 ARC Medical Devices Highly sulfated fucans for the treatment of fibrous adhesions

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
본 출원은 다음 공개문헌 전체를 참고로 포함한다: 2019년 7월 24일 출원된 PCT/CA2019/051025; 2019년 7월 24일 출원된 PCT/CA2019/051026; 2019년 7월 24일 출원된 PCT/CA2019/051027, 2019년 7월 24일 출원된 PCT/CA2019/051030; 2019년 7월 24일 출원된 PCT/CA2019/051028; 2020년 3월 5일 출원된 PCT/CA2020/050294; 2020년 3월 5일 출원된 PCT/CA2020/050295; 및 2019년 7월 24일 출원된 PCT/CA2019/051029.

Also Published As

Publication number Publication date
MX2024002190A (es) 2024-06-24
WO2023019360A1 (en) 2023-02-23
US20240350531A1 (en) 2024-10-24
EP4387630A4 (en) 2025-07-30
ZA202401941B (en) 2025-06-25
IL310940A (en) 2024-04-01
JP2024532867A (ja) 2024-09-10
EP4387630A1 (en) 2024-06-26
AU2022328865A1 (en) 2024-03-14
CA3229366A1 (en) 2023-02-23

Similar Documents

Publication Publication Date Title
Zhang et al. A self-healing hydrogel wound dressing based on oxidized Bletilla striata polysaccharide and cationic gelatin for skin trauma treatment
US6974805B2 (en) Configuration of glycosaminoglycans
EP2121048B1 (en) Hemostatic compositions and therapeutic regimens
US20100215731A1 (en) Method for improving cartilage repair and/or preventing cartilage degeneration in a joint
JP2018198954A (ja) 改良医療デバイス
HK1219242A1 (zh) 抗血栓形成移植物
AU2007331071A1 (en) Novel injectable chitosan mixtures forming hydrogels
KR20150111372A (ko) 주사 시술용 보형물
US20210196863A1 (en) Hydrogel for endogenous neuroprogenitor cell recruitment
Wang et al. Construction of cytokine reservoirs based on sulfated chitosan hydrogels for the capturing of VEGF in situ
CN116102884A (zh) 聚乙烯亚胺-聚丙烯酸-壳聚糖水凝胶、制备方法及应用
KR20240087708A (ko) 구형구축과 관련된 상태의 치료 및 이식체나 그 주위의 섬유성장 억제를 위한 푸칸 및 개질 푸칸 조성물
Salehi et al. Chitosan/alginate hydrogel adorned with nanoemulsions for potential wound healing: Fabrication, characterization, and biocompatibility evaluation
JP6933393B2 (ja) 皮膚異常の処置のための治療用化粧品
Reddy et al. Curcumin and chitosan loaded nano scaffold for targeting chronic wounds through tissue engineering in regenerative medicine.
CN118302175A (zh) 用于治疗与包膜挛缩相关的病症和抑制在移植物周围或移植物上的纤维生长的岩藻聚糖和改性岩藻聚糖组合物
HK40106155A (zh) 用於治疗与包膜挛缩相关的病症和抑制在移植物周围或移植物上的纤维生长的岩藻聚糖和改性岩藻聚糖组合物
KR102939560B1 (ko) 생체적합성 고분자와 하이드록시에틸전분을 함유한 파우더형 유착방지제 및 이의 제조방법
Li et al. Porcine plasma protein cold-set hydrogel crosslinked by genipin and the immunomodulatory, proliferation promoting and scar-remodeling in wound healing
EP2968402B1 (en) Medical device having a coating comprising accs
Gorst The synthesis, characterisation and biological evaluation of chitin and chitosan materials
Mondalek Modification of the small intestinal submucosa using PLGA nanoparticles for enhanced tissue regeneration: From in vitro to in vivo models
HK1173685B (en) Hemostatic compositions and therapeutic regimens
HK1137370B (en) Hemostatic compositions and therapeutic regimens
HK1173685A (en) Hemostatic compositions and therapeutic regimens

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20240320

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application